Display Settings:

Format

Send to:

Choose Destination

    Ann Trop Med Parasitol. 1997 Jun;91(4):379-91.

    Country-wide rapid epidemiological mapping of onchocerciasis (REMO) in Cameroon.

    Macé JM, Boussinesq M, Ngoumou P, Enyegue Oye J, Koéranga A, Godin C.

    GEOS, Université Paul Valéry Montpellier III, France.

    The prevalence of infection in local communities has been used as the basis for the country-wide repartition of onchocerciasis in Cameroon, following the principles for rapid epidemiological mapping of onchocerciasis (REMO) developed by the World Health Organization. The levels of endemicity were evaluated in 349 villages by rapid epidemiological assessment (REA), a method based on the examination of nodules in males aged > or = 20 years. An onchocerciasis map was then drawn from the epidemiological data which had been collected previously, from clinico-parasitological surveys based on the examination of skin snips, and the results of the REA surveys. The REMO surveys allowed the main onchocerciasis foci in Cameroon to be accurately delineated, and several small endemic areas which had never been reported before to be identified. The total 'at risk' population (i.e. those for which ivermectin treatment should be considered as urgent or highly desirable) was estimated by combining the epidemiological results and the demographical data available from an administrative census. Those at risk were estimated to number 3.5 million, representing about 50% of the total rural population in Cameroon.

    PMID: 9290845 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Ivermectin (Stromectol®)

      Ivermectin is used to treat strongyloidiasis (threadworm; infection with a type of roundworm that enters the body through the skin, moves through the airways and lives in the intestines). Ivermectin is also used to contr...

    Search details

    » See more...